The EPS and share price divergence suggests past growth expe...
The EPS and share price divergence suggests past growth expectations may have been unreasonable. The recent sell-off could be a long-term investor opportunity, but signs of a long-term growth trend are crucial. Investors should also be aware of a warning sign for Yantai Zhenghai Biotechnology.
Earnings Are Growing at Yantai Zhenghai Biotechnology (SZSE:300653) but Shareholders Still Don't Like Its Prospects
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment